Mitochondrial degradation of amyloidogenic proteins — A new perspective for neurodegenerative diseases
- 1 October 2019
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 181, 101660
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
- Wellcome Trust
- UK Medical Research Council (MRC)
- Alzheimer Research UK (ARUK)
- Infinitus China Ltd
This publication has 91 references indexed in Scilit:
- TOM40 Mediates Mitochondrial Dysfunction Induced by α-Synuclein Accumulation in Parkinson’s DiseasePLOS ONE, 2013
- Human CLPP reverts the longevity phenotype of a fungal ClpP deletion strainNature Communications, 2013
- Mitochondrial Ca2+ and neurodegenerationCell Calcium, 2012
- Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repairNature Reviews Neuroscience, 2012
- Genetic variation of Omi/HtrA2 and Parkinson's diseaseParkinsonism & Related Disorders, 2008
- A Mitochondrial Protein Compendium Elucidates Complex I Disease BiologyCell, 2008
- Dissecting the ER-Associated Degradation of a Misfolded Polytopic Membrane ProteinCell, 2008
- Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondriaProceedings of the National Academy of Sciences, 2006
- α-synuclein locus duplication as a cause of familial Parkinson's diseaseThe Lancet, 2004
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991